Inspire Selling And Marketing Expenses from 2010 to 2024
| INSP Stock | USD 194.00 4.87 2.57% |
Selling And Marketing Expenses | First Reported 2010-12-31 | Previous Quarter 100.3 M | Current Value 105.3 M | Quarterly Volatility 31.6 M |
Check Inspire Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inspire Medical's main balance sheet or income statement drivers, such as Interest Income of 19 M, Depreciation And Amortization of 1.7 M or Interest Expense of 0.0, as well as many indicators such as Price To Sales Ratio of 9.06, Dividend Yield of 0.0 or PTB Ratio of 9.89. Inspire financial statements analysis is a perfect complement when working with Inspire Medical Valuation or Volatility modules.
Inspire | Selling And Marketing Expenses |
Latest Inspire Medical's Selling And Marketing Expenses Growth Pattern
Below is the plot of the Selling And Marketing Expenses of Inspire Medical Systems over the last few years. It is Inspire Medical's Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inspire Medical's overall financial position and show how it may be relating to other accounts over time.
| Selling And Marketing Expenses | 10 Years Trend |
|
Selling And Marketing Expenses |
| Timeline |
Inspire Selling And Marketing Expenses Regression Statistics
| Arithmetic Mean | 35,931,000 | |
| Geometric Mean | 27,223,859 | |
| Coefficient Of Variation | 87.91 | |
| Mean Deviation | 24,532,133 | |
| Median | 18,000,000 | |
| Standard Deviation | 31,588,198 | |
| Sample Variance | 997.8T | |
| Range | 90M | |
| R-Value | 0.81 | |
| Mean Square Error | 377T | |
| R-Squared | 0.65 | |
| Significance | 0.0003 | |
| Slope | 5,691,057 | |
| Total Sum of Squares | 13969.4T |
Inspire Selling And Marketing Expenses History
About Inspire Medical Financial Statements
Inspire Medical shareholders use historical fundamental indicators, such as Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Although Inspire Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Inspire Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Inspire Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 100.3 M | 105.3 M |
Pair Trading with Inspire Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Inspire Stock
| 0.62 | DXCM | DexCom Inc | PairCorr |
| 0.59 | LH | Laboratory | PairCorr |
| 0.54 | VREX | Varex Imaging Corp | PairCorr |
| 0.48 | GH | Guardant Health | PairCorr |
| 0.43 | OM | Outset Medical | PairCorr |
The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.
The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.